Open-Angle Glaucoma Drugs Market is segmented By Types of Open-Angle Glaucoma (Primary Open-Angle Glaucoma, Secondary Open-Angle Glaucoma), By Risk Factors (General Factors, Ocular Factors, Non-ocular Factors, Ocular Hypertension), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
Market Size in USD
CAGR8%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 8% |
Market Concentration | High |
Major Players | Aerie Pharmaceuticals, Alcon Research, Allergan, Bausch and Lomb, Chong Kun Dang Pharmaceutical |
The open-angle glaucoma drugs market is estimated to be valued at USD 8.51 Bn in 2024 and is expected to reach USD 14.6 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8% from 2024 to 2031. This growth can be attributed to the increasing prevalence of glaucoma due to rising geriatric population and growing awareness about early detection and treatment of the condition.